[ad_1]
The modern vaccine is the second that the EEA has recommended for distribution in the European Union. At the end of December, the green light was lit to start vaccination with a preparation developed by Pfizer and BioNTech.
“We are giving more COVID-19 vaccines to Europeans. With the Moderna vaccine, now the second in the EU to be approved, we will receive another 160 million doses. And there will be more vaccines,” says the von der Leyen report.
The European Commission has already commissioned 80 million euros. Modern vaccine doses to supply to EU members, with the possibility of ordering another 80 million. dose. The block also agrees to buy 300 million. doses of the Pfizer-BioNTech vaccine. Both types of vaccines are given in two doses.
“This vaccine gives us another tool to overcome the current emergency,” said Emer Cooke, executive director of the EEA. – This is a testament to the efforts and commitments of everyone involved as we have a second positive recommendation on the vaccine, almost a year after the WHO. [Pasaulio sveikatos organizacijos] declaration of a pandemic “.
Stela Kiriakides, European Commissioner for Health and Food Safety, said that “460 million doses of vaccine are distributed at an increasing rate in the EU, and [vėliau] more will come. Member States shall ensure that the vaccination rate is adequate. “
German Health Minister Jens Spahn, who had previously criticized the EEA’s slowness, expressed hope that EU countries will start receiving the Moderna vaccine next week before the agency issued its latest recommendation.
Germany is expected to receive $ 2 million in the first quarter. doses, and 50 million for all this year. dose, Spahn told reporters in Berlin.
“The problem is the lack of production capacity given global demand,” he explained.
Early results from large but pending clinical trials suggest that Moderna and Pfizer-BioNTech vaccines appear to be safe and effective. However, Moderna’s logistics are simpler as it does not need to be stored at extremely low temperatures.
The EVA has recommended that Moderna be given to people 18 years of age and older. The agency noted that the side effects of the vaccine “are usually mild to moderate and [paskiepytieji] feel better a few days after vaccination ”.
The most common side effects were “pain and swelling at the injection site, fatigue, chills, fever, swollen or tender lymph nodes in the armpits, headache, muscle and joint pain, nausea and vomiting,” said the report from the EMA.
Mr Cook emphasized that the EU services would “closely monitor the data on the safety and efficacy of the vaccine to ensure the protection of the EU public.” Our work will always be based on scientific evidence and a commitment to protect the health of EU citizens. “
The Moderna vaccine has already been approved in the United States, Canada, and Israel.
The company said Monday that it forecasts it will be able to produce $ 600 million this year. doses of vaccines – 100 million. dose more than previously planned. Moderna added that it continues to invest and hire staff to increase production capacity to $ 1 billion. doses during the year 2021.
[ad_2]
